| Literature DB >> 14987981 |
Sandra Piras1, Mario Loriga, Giuseppe Paglietti.
Abstract
Fourteen out of 21 quinoxaline derivatives described in the present paper were selected at NCI for evaluation of their in vitro anticancer activity. Preliminary screening showed that some derivatives exhibited a moderate to strong growth inhibition activity on various tumor panel cell lines between 10(-5) and 10(-4) M concentrations. Interesting selectivities were also recorded between 10(-8) and 10(-6) M for the compounds 9 and 13.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14987981 DOI: 10.1016/j.farmac.2003.11.014
Source DB: PubMed Journal: Farmaco ISSN: 0014-827X